Suppr超能文献

舒必利所致迟发性运动障碍。

Tardive dyskinesia induced by sulpiride.

作者信息

Achiron A, Zoldan Y, Melamed E

机构信息

Department of Neurology, Beilinson Medical Center, Petach-Tiqva, Israel.

出版信息

Clin Neuropharmacol. 1990 Jun;13(3):248-52. doi: 10.1097/00002826-199006000-00008.

Abstract

Although tardive dyskinesia is a known adverse reaction of sustained treatment with traditional neuroleptic agents, it was only rarely reported in association with sulpiride, a selective D2-receptor antagonist. We describe six patients who developed tardive dyskinesia after treatment with sulpiride for depression or gastrointestinal symptoms. In three patients, involuntary movements emerged during the course of treatment and in the others only after discontinuation of the drug. These cases indicate that sulpiride can cause tardive dyskinesia and that this drug should be administered with caution.

摘要

虽然迟发性运动障碍是传统抗精神病药物持续治疗已知的不良反应,但与选择性D2受体拮抗剂舒必利相关的报道却很少。我们描述了6例在使用舒必利治疗抑郁症或胃肠道症状后出现迟发性运动障碍的患者。3例患者在治疗过程中出现不自主运动,其他患者则在停药后才出现。这些病例表明舒必利可导致迟发性运动障碍,应谨慎使用该药。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验